Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study

Clinical trial NCT06335407 · RECRUITING

Trial details

NCT number: NCT06335407
Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alcohol Use Disorder (AUD)Post Traumatic Stress Disorder (PTSD)

Start date: 2025-07-28
Primary completion: 2026-03-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.